T-cell receptor biases and clonal proliferations in blood and pleural effusions of patients with lung cancer

Human Immunology

Volumn 53, Issue 1, 1997, Pages 39-48

  Duncan, Steven R ^a   Elias, Darlene J ^a   Roglic, Mihovil ^a   Pekny, Katherine W ^a   Theofilopoulos, Argyrios N ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b IMM3 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOREGULATION; LUNG CARCINOMA; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PLEURA EFFUSION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AGED; ANTIGENS, NEOPLASM; CARCINOMA, BRONCHOGENIC; CELL DIVISION; CLONE CELLS; CLONING, MOLECULAR; GENE LIBRARY; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MULTIGENE FAMILY; PLEURAL EFFUSION, MALIGNANT; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0030960762     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(96)00296-0     Document Type: Article

References (43)

1. Boring CC, Squires TS, Tong T, Montgomery S: Cancer statistics 1994. Cancer J.
2. Marini N, Beattie EJ: Results of surgical treatment in Stage I lung cancer. J. Thorac Clin 44:7, 1994,
3. Cardiovasc. Surg 74:499, 1977.
4. Sensi M, Parmiani G: Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol Today 12:588, 1995.
5. Pardoll, DM: Tumor antigens: a new look for the 1990s. Nature 369:357, 1994.
6. Van den Eynde B, Brichard, VG: New tumor antigens recognized by T cells. Curr Opinion Immunol 7:674, 1995.
7. Tsomides TJ, Eisen HH: T-cell antigens in cancer. Proc Natl Acad Sci USA. 91:3487, 1994.
8. Boon T, Bruggen PV: Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725, 1996.
9. Ioannides CG, Whiteside, TL: T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopath 66:91, 1993.
10. Leach DR, Krummel MF, Allison JP: Enchancement of antitumor immunity by CTLA-4 blockade. Science 271: 1734, 1996.
11. Allison JP, Hurwitz AA, Leach, DR: Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opinion Immunol 7:682, 1995.
12. Boon T, Gajewski TJ, Coulie, PG: From defined human tumor antigens to effective immunization. Immunol Today 16:334, 1995.
13. Nanda NK, Sercarz EE: Induction of anti-self-immunity to cure cancer. Cell 82:13, 1995.
14. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87, 1996.
15. Moss PAH, Rosenberg WMC, Bell JI: The human T cell receptor in health and disease. Annu Rev Immunol 10:71, 1992.
16. Sahn SA: Pleural effusion in lung cancer. Clin Chest Med 14:189, 1993.
17. Duncan SR, Valentine V, Roglic M, Elias DJ, Pekny KW, Theodore J, Kono DH, Theofilopoulos AN: T-cell clonal proliferations in lung transplant recipients with obliterative bronchiolitis. J Clin Invest 97:2642, 1996.
18. Baccala R, Kono DH, Walker SM, Balderas RS, Theofilopoulos AN: Genomically imposed and somatically modified human thymocyte Vβ gene repertoires. Proc Natl Acad Sci USA. 88:2908, 1991.
19. Kono DH, Baccala R, Balderas RS, Kovac SJ, Heald PW, Edelson RI, Theofilopoulos AN: Application of a multiprobe RNase protection assay and junction sequences to define Vβ gene diversity in Sezary Syndrome. Am J Pathol 140:823, 1992.
20. Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN: Identification of clonally-expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 97:1335, 1996.
21. Meyer PC: Metastatic carcinoma of the pleura. Thorax 21:437, 1966.
22. Chernow B, Sahn SA: Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 63:695, 1977.
23. Domagala W, Emerson EE, Kass, LG: Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions in patients with cancer. J Natl Cancer Inst 61:295, 1977.
24. Sprent J: T and B memory cells. Cell 76:315, 1994.
25. Lehmann D, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, Boon T, Coulie PG: Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol 25:340, 1995.
26. Bennett WT, Padolfi F, Grove BH, Hawes GE, Boyle LA, Kradin KL, Kurnick JT: Dominant rearrangements among human tumor-infiltrating lymphocytes. Cancer 69:2379, 1992.
27. Melioli G, Ratto GB, Guastella M, Meta M, Biassoni R, Semino C, Casartelli G, Pasquetti W, Catrullo A, Moretta L: Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma. Eur J Cancer 30: 97, 1994.
28. Meta M, Ponte M, Guastella M, Semino C, Pietra G, Ratto GB, Melioli G: Detection of oligoclonal T lymphocytes in lymph nodes draining from advanced non-small-cell lung cancer. Cancer Immunol Immunother 40:235, 1995.
29. Manca F, Fenoglio D, Valle MT, Li Pira G, Kunkl A, Balderas RS, Baccala R, Kono DH, Theofilopoulos AN: Clonal heterogeneity of the human T helper repertoire specific for HIV reverse transcriptase. Eur J Immunol 25:1217, 1995.
30. Yoshino I, Yano T, Yoshikai Y, Murata M, Sugimachi K, Kimura G, Nomoto K: Oligoclonal T lymphocytes infiltrating human lung cancer tissues. Int J Cancer 47:654, 1991.
31. Akolkar PN, Gulwani-Akolkar B, Pergolizzi R, Bigler RD, Silver, J: Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol 150:2761, 1993.
32. Currier JR, Yassai M, Robinson MA, Gorski J: Molecular defects in TCRBV genes preclude thymic selection and limit the expressed TCR repertoire. J Immunol 157:170, 1996.
33. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67, 1994.
34. Couline P, Lehmann F, Lethe B, Herman J, Lurquin C, Andrawiss M, Boon T: A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92:7976, 1995.
35. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, Plaen DE, Hankeln T, Meyer zum Buschenfelde KH, Beach D: A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281, 1995.
36. Jung S, Schleusener, HJ: Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J Exp Med 173:273, 1991.
37. Jerome KR, Domenech N, Finn OJ: Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin cDNA. J Immunol 151:1654, 1993.
38. Topalian SL, Rivoltini L, Mancini M, Marjus MN, Robbins PF, Kawakami Y, Rosenberg SA: Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 91:9461, 1994.
39. Takahashi T, Chapman PB, Yang SY, Hara I, Vijayasara-dhi S, Houghton AN: Reactivity of autologous CD4 + T lymphocytes against human melanoma. J Immunol 154: 772, 1995.
40. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W: Immunity to oncogenic proteins. Immunol Rev 145:33, 1995.
41. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO: HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol 63: 1756, 1989.
42. Celis E, Ou D, Otvos L: Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferation and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J Immunol 140:1808, 1988.
43. Takeshita T, Takahashi H, Kozlowski S, Ahlers JD, Pendleton CD, Morre RL, Nakagawa Y, Yokomuro K, Fox BS, Murgulies DH, Berzofsky JA: Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II molecule. J Immunol 154:1973, 1995.